Drug Profile
Hepatitis C antibody - MRC Technology/NewSummit Biopharma
Latest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator MRC Technology; University of Glasgow
- Developer LifeArc
- Class Antibodies; Antivirals
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hepatitis C